Page last updated: 2024-08-22

butoxamine and Pancreatic Neoplasms

butoxamine has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, H; Ma, Q; Shen, S; Zhang, D	1

Other Studies

1 other study(ies) available for butoxamine and Pancreatic Neoplasms

Article	Year
Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell. Pancreas, 2009, Volume: 38, Issue:1 Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Annexin A5; Antineoplastic Agents; Apoptosis; Butoxamine; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Metoprolol; Pancreatic Neoplasms; Propranolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; RNA, Messenger	2009

Article

Year

Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell.

Pancreas, 2009, Volume: 38, Issue:1

Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Annexin A5; Antineoplastic Agents; Apoptosis; Butoxamine; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Metoprolol; Pancreatic Neoplasms; Propranolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; RNA, Messenger

2009